Viropharma, Inc. (VPHM) Tops Q3 EPS by 15c; Updates Outlook
Tweet Send to a Friend
Viropharma, Inc. (NASDAQ: VPHM) reported Q3 adjusted EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
